Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa

Journal of Clinical Microbiology

Volumn 51, Issue 6, 2013, Pages 1818-1825

  Marais, Ben J ^a   Mlambo, Charmaine K ^b   Rastogi, Nalin ^c   Zozio, Thierry ^c   Duse, Adriano G ^b   Victor, Thomas C ^d   Marais, Else ^b   Warrend, Robin M ^d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c Institut Pasteur de Guadeloupe   (Guadeloupe)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADULT; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG SENSITIVITY; EPIDEMIC; FEMALE; GENOTYPE; HUMAN; INTERSPERSED REPEAT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SOUTH AFRICA; SPUTUM ANALYSIS; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EPIDEMICS; FEMALE; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; MYCOBACTERIUM TUBERCULOSIS; SOUTH AFRICA; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84878502169     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00200-13     Document Type: Article

References (49)

1. Mitchison D, Davies G. 2012. The chemotherapy of tuberculosis: past, present and future. Int. J. Tuberc. Lung Dis. 16:724-732.
2. Raviglione MC, Pio A. 2002. Evolution of WHO policies for tuberculosis control, 1948-2001. Lancet 359:775-780. (Pubitemid 34215081)
3. Raviglione M, Marais B, Floyd K, Lonnroth K, Getahun H, Migliori GB, Harries AD, Nunn P, Lienhardt C, Graham S, Chakaya J, Weyer K, Cole S, Kaufmann SH, Zumla A. 2012. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 379:1902-1913.
4. Middlebrook G, Cohn ML. 1953. Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science 118:297-299.
5. Dye C, Espinal MA. 2001. Will tuberculosis become resistant to all antibiotics? Proc. R. Soc. Lond. B Biol. Sci. 268:45-52. (Pubitemid 32127952)
6. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G. 2006. Extensively drug resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368:1575-1580. (Pubitemid 44780738)
7. Moss AR, Alland D, Telzak E, Hewlett D, Jr, Sharp V, Chiliade P, LaBombardi V, Kabus D, Hanna B, Palumbo L, Brudney K, Weltman A, Stoeckle K, Chirgwin K, Simberkoff M, Moghazeh S, Eisner W, Lutfey M, Kreiswirth B. 1997. A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York. Int. J. Tuberc. Lung Dis. 1:115-121. (Pubitemid 127509666)
8. WHO. 2006. The Stop TB strategy. World Health Organization, Geneva, Switzerland. http://www.who.int/tb/strategy/stop-tb-strategy/en/index.html. Accessed 12 January 2012.
9. Nathanson E, Nunn P, Uplekar M, Floyd K, Jaramillo E, Lonnroth K, Weil D, Raviglione M. 2010. MDR tuberculosis- critical steps for prevention and control. N. Engl. J. Med. 363:1050-1058.
10. WHO. 2012. Global tuberculosis report 2012. World Health Organization, Geneva, Switzerland. http://apps.who.int/iris/bitstream/10665/75938/1/ 9789241564502-eng.pdf. Accessed 10 December 2012.
11. Zumla A, Abubakar I, Raviglione M, Hoelscher M, Ditiu L, McHugh TD, Squire SB, Cox H, Ford N, McNerney R, Marais B, Grobusch M, Lawn SD, Migliori GB, Mwaba P, O'Grady J, Pletschette M, Ramsay A, Chakaya J, Schito M, Swaminathan S, Memish Z, Maeurer M, Atun R. 2012. Drug-resistant tuberculosis- current dilemmas, unanswered questions, challenges, and priority needs. J. Infect. Dis. 205(Suppl 2):S228-S240.
12. Ben AY, Nemser B, Singh A, Sankin A, Schluger N. 2008. Underreported threat of multidrug-resistant tuberculosis in Africa. Emerg. Infect. Dis. 14:1345-1352.
13. Verver S, Warren RM, Beyers N, Richardson M, van der Spuy GD, Borgdorff MW, Enarson DA, Behr MA, van Helden PD. 2005. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am. J. Respir. Crit. Care Med. 171:1430-1435. (Pubitemid 40800517)
14. Gardy JL, Johnston JC, Ho Sui SJ, Cook VJ, Shah L, Brodkin E, Rempel S, Moore R, Zhao Y, Holt R, Varhol R, Birol I, Lem M, Sharma MK, Elwood K, Jones SJ, Brinkman FS, Brunham RC, Tang P. 2011. Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N. Engl. J. Med. 364:730-739.
15. Sola C, Filliol I, Gutierrez MC, Mokrousov I, Vincent V, Rastogi N. 2001. Spoligotype database of Mycobacterium tuberculosis: biogeographic distribution of shared types and epidemiologic and phylogenetic perspectives. Emerg. Infect. Dis. 7:390-396.
16. Supply P, Lesjean S, Savine E, Kremer K, van Soolingen D, Locht C. 2001. Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J. Clin. Microbiol. 39:3563-3571. (Pubitemid 32954502)
17. Grant J, Kammerer S, Baker B, Kim L. 2012. Tuberculosis genotyping - United States, 2004-2010. MMWR Morb. Mortal. Wkly. Rep. 61:723-725.
18. Johnson R, Warren RM, van der Spuy GD, Gey Van Pittius NC, Theron D, Streicher EM, Bosman M, Coetzee GJ, van Helden PD, Victor TC. 2010. Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. Int. J. Tuberc. Lung Dis. 14:119-121.
19. Statistics South Africa. 2009. Mid-year population estimates 2009. http://www.statssa.gov.za/publications/P0302/P03022009.PDF. Accessed 1 October 2012.
20. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, Van Embden J. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914. (Pubitemid 27146535)
21. Streicher EM, Victor TC, van der Spuy G, Sola C, Rastogi N, van Helden PD, Warren RM. 2007. Spoligotype signatures in the Mycobacterium tuberculosis complex. J. Clin. Microbiol. 45:237-240. (Pubitemid 46106435)
22. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, Bifani P, Kurepina N, Kreiswirth B, Sola C, Rastogi N, Vatin V, Gutierrez MC, Fauville M, Niemann S, Skuce R, Kremer K, Locht C, van Soolingen D. 2006. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J. Clin. Microbiol. 44:4498-4510. (Pubitemid 44937085)
23. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al Hajoj SA, Allix C, Aristimuno L, Arora J, Baumanis V, Binder L, Cafrune P, Cataldi A, Cheong S, Diel R, Ellermeier C, Evans JT, Fauville-Dufaux M, Ferdinand S, Garcia de Viedma D, Garzelli C, Gazzola L, Gomes HM, Gutierrez MC, Hawkey PM, van Helden PD, Kadival GV, Kreiswirth BN, Kremer K, Kubin M, Kulkarni SP, Liens B, Lillebaek T, Ly HM, Martin C, Martin C, Mokrousov I, Narvskaia O, Ngeow YF, Naumann L, Niemann S, Parwati I, Rahim MZ, Rasolofo-Razanamparany V, Rasolonavalona T, Rossetti ML, Rusch-Gerdes S, Sajduda A, Samper S, Shemyakin I, Singh UB, Somoskovi A, Skuce R, van Soolingen D, Streicher EM, Suffys PN, Tortoli E, Tracevska T, Vincent V, Victor TC, Warren R, Yap SF, Zaman K, Portaels F, Rastogi N, Sola C. 2006. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol. 6:23.
24. Demay C, Liens B, Burguiere T, Hill V, Couvin D, Millet J, Mokrousov I, Sola C, Zozio T, Rastogi N. 2012. SITVITWEB-a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect. Genet. Evol. 12:755-766.
25. Hunter PR, Gaston MA. 1988. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J. Clin. Microbiol. 26:2465-2466.
26. Cohen T, Murray M. 2004. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat. Med. 10:1117-1121. (Pubitemid 39424874)
27. Borgdorff MW, Sebek M, Geskus RB, Kremer K, Kalisvaart N, Van SD. 2011. The incubation period distribution of tuberculosis estimated with a molecular epidemiological approach. Int. J. Epidemiol. 40:964-970.
28. Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJ. 2006. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312:1944-1946. (Pubitemid 43993719)
29. Calver AD, Falmer AA, Murray M, Strauss OJ, Streicher EM, Hanekom M, Liversage T, Masibi M, van Helden PD, Warren RM, Victor TC. 2010. Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa. Emerg. Infect. Dis. 16:264-271.
30. Uys PW, Warren R, van Helden PD, Murray M, Victor TC. 2009. Potential of rapid diagnosis for controlling drug-susceptible and drug-resistant tuberculosis in communities where Mycobacterium tuberculosis infections are highly prevalent. J. Clin. Microbiol. 47:1484-1490.
31. Perez-Velez CM, Marais BJ. 2012. Tuberculosis in children. N. Engl. J. Med. 367:348-361.
32. Hesseling AC, Kim S, Madhi S, Nachman S, Schaaf HS, Violari A, Victor TC, McSherry G, Mitchell C, Cotton MF. 2012. High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trial. Int. J. Tuberc. Lung Dis. 16:192-195.
33. Strauss OJ, Warren RM, Jordaan A, Streicher EM, Hanekom M, Falmer AA, Albert H, Trollip A, Hoosain E, van Helden PD, Victor TC. 2008. Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence. J. Clin. Microbiol. 46:1514-1516. (Pubitemid 351563605)
34. Seddon JA, Hesseling AC, Marais BJ, Jordaan A, Victor T, Schaaf HS. 2012. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa. Int. J. Tuberc. Lung Dis. 16:928-933.
35. Lawn SD, Bekker LG, Middelkoop K, Myer L, Wood R. 2006. Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. Clin. Infect. Dis. 42:1040-1047.
36. Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, Marais E. 2008. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int. J. Tuberc. Lung Dis. 12:99-104.
37. Chihota VN, Muller B, Mlambo CK, Pillay M, Tait M, Streicher EM, Marais E, van der Spuy GD, Hanekom M, Coetzee G, Trollip A, Hayes C, Bosman ME, Gey Van Pittius NC, Victor TC, van Helden PD, Warren RM. 2012. Population structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa. J. Clin. Microbiol. 50:995-1002.
38. Chihota V, Apers L, Mungofa S, Kasongo W, Nyoni IM, Tembwe R, Mbulo G, Tembo M, Streicher EM, van der Spuy GD, Victor TC, van Helden P, Warren RM. 2007. Predominance of a single genotype of Mycobacterium tuberculosis in regions of southern Africa. Int. J. Tuberc. Lung Dis. 11:311-318. (Pubitemid 46447440)
39. Shah NS, Richardson J, Moodley P, Moodley S, Babaria P, Ramtahal M, Heysell SK, Li X, Moll AP, Friedland G, Sturm AW, Gandhi NR. 2011. Increasing drug resistance in extensively drug-resistant tuberculosis, South Africa. Emerg. Infect. Dis. 17:510-513.
40. Drobniewski F, Balabanova Y, Nikolayevsky V, Ruddy M, Kuznetzov S, Zakharova S, Melentyev A, Fedorin I. 2005. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA 293:2726-2731. (Pubitemid 40965084)
41. Toungoussova OS, Sandven P, Mariandyshev AO, Nizovtseva NI, Bjune G, Caugant DA. 2002. Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J. Clin. Microbiol. 40:1930-1937. (Pubitemid 34596365)
42. Marais BJ, Victor TC, Hesseling AC, Barnard M, Jordaan A, Brittle W, Reuter H, Beyers N, van Helden PD, Warren RM, Schaaf HS. 2006. Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa. J. Clin. Microbiol. 44:3539-3543. (Pubitemid 46768796)
43. Almeida D, Rodrigues C, Ashavaid TF, Lalvani A, Udwadia ZF, Mehta A. 2005. High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. Clin. Infect. Dis. 40:881-886. (Pubitemid 40365511)
44. van der Spuy GD, Kremer K, Ndabambi SL, Beyers N, Dunbar R, Marais BJ, van Helden PD, Warren RM. 2009. Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics. Tuberculosis (Edinb.) 89:120-125.
45. Hanekom M, Gey Van Pittius NC, McEvoy C, Victor TC, van Helden PD, Warren RM. 2011. Mycobacterium tuberculosis Beijing genotype: a template for success. Tuberculosis (Edinb.) 91:510-523.
46. Abebe F, Bjune G. 2006. The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guerin (BCG) vaccines: is there a link? Clin. Exp. Immunol. 145:389-397. (Pubitemid 44252479)
47. Toungoussova OS, Caugant DA, Sandven P, Mariandyshev AO, Bjune G. 2004. Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype. FEMS Immunol. Med. Microbiol. 42:281-290. (Pubitemid 39346120)
48. Murray EJ, Marais BJ, Mans G, Beyers N, Ayles H, Godfrey-Faussett P, Wallman S, Bond V. 2009. A multidisciplinary method to map potential tuberculosis transmission 'hot spots' in high-burden communities. Int. J. Tuberc. Lung Dis. 13:767-774.
49. Marais BJ, Raviglione MC, Donald PR, Harries AD, Kritski AL, Graham SM, El-Sadr WM, Harrington M, Churchyard G, Mwaba P, Sanne I, Kaufmann SH, Whitty CJ, Atun R, Zumla A. 2010. Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet 375:2179-2191.